A national survey of oncologist and chest physicians’ attitudes towards empirical anti-oestrogen therapy,early pleurodesis and preference of sclerosing agent in malignant breast and ovarian pleural disease

Antunes G , Neville E , Duffy J , et al. BTS guidelines for the management of malignant pleural effusions . Thorax 2003; 58: ii29–ii38 .

Lee YC , Lane KB , Zoia O , Thompson PJ , Light RW , Blackwell TS . Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells . Eur Respir J 2003; 22: 197–202 .

Barbetakis N , Vassiliadis M , Kaplanis K , Valeri R , Tsilikas C . Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer . BMC Palliative Care 2004; 3: 4–9 .

Barbetakis N , Antoniadis T , Tsilikas C . Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer World J Surg Oncol 2004; 2: 16–22 .

Maskell NA , Lee YC , Gleeson FV , Hedley EL , Pengelly G , Davies RJ . Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size . Am J Respir Crit Care Med 2004; 170: 377–382 .